# Azelaic Acid as a Novel Treatment for Central Centrifugal Cicatricial Alopecia (CCCA)

> **NCT05416333** · EARLY_PHASE1 · ACTIVE_NOT_RECRUITING · sponsor: **Wake Forest University Health Sciences** · enrollment: 18 (actual)

## Conditions studied

- Central Centrifugal Cicatricial Alopecia

## Interventions

- **DRUG:** azelaic acid
- **OTHER:** usual medication for CCCA

## Key facts

- **NCT ID:** NCT05416333
- **Lead sponsor:** Wake Forest University Health Sciences
- **Sponsor class:** OTHER
- **Phase:** EARLY_PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** ACTIVE_NOT_RECRUITING
- **Start date:** 2024-08-12
- **Primary completion:** 2026-05
- **Final completion:** 2026-12
- **Target enrollment:** 18 (ACTUAL)
- **Last updated:** 2026-02-13


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT05416333

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT05416333, "Azelaic Acid as a Novel Treatment for Central Centrifugal Cicatricial Alopecia (CCCA)". Retrieved via AI Analytics 2026-07-04 from https://api.ai-analytics.org/clinical/NCT05416333. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*